Annual EBIT
-$482.02 M
+$46.55 M+8.81%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual earnings before interest & taxes is -$482.02 million, with the most recent change of +$46.55 million (+8.81%) on December 31, 2023.
- During the last 3 years, BPMC annual EBIT has fallen by -$790.73 million (-256.14%).
- BPMC annual EBIT is now -256.14% below its all-time high of $308.71 million, reached on December 31, 2020.
Performance
BPMC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$37.24 M
-$4.14 M-12.53%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly earnings before interest & taxes is -$37.24 million, with the most recent change of -$4.14 million (-12.53%) on September 30, 2024.
- Over the past year, BPMC quarterly EBIT has increased by +$83.14 million (+69.07%).
- BPMC quarterly EBIT is now -105.88% below its all-time high of $633.37 million, reached on September 30, 2020.
Performance
BPMC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$89.40 M
+$83.14 M+48.19%
September 30, 2024
Summary
- As of February 7, 2025, BPMC TTM earnings before interest & taxes is -$89.40 million, with the most recent change of +$83.14 million (+48.19%) on September 30, 2024.
- Over the past year, BPMC TTM EBIT has increased by +$414.41 million (+82.25%).
- BPMC TTM EBIT is now -126.40% below its all-time high of $338.65 million, reached on June 30, 2021.
Performance
BPMC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BPMC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.8% | +69.1% | +82.3% |
| 3 y3 years | -256.1% | +69.2% | +82.3% |
| 5 y5 years | -95.1% | +69.2% | +82.3% |
BPMC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.0% | -135.7% | +88.0% | at high | +87.1% |
| 5 y | 5-year | -256.1% | +24.0% | -105.9% | +88.0% | -126.4% | +87.1% |
| alltime | all time | -256.1% | +24.0% | -105.9% | +88.0% | -126.4% | +87.1% |
Blueprint Medicines EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.24 M(+12.5%) | -$89.40 M(-48.2%) |
| Jun 2024 | - | -$33.09 M(-131.7%) | -$172.54 M(-33.7%) |
| Mar 2024 | - | $104.39 M(-184.6%) | -$260.31 M(-46.0%) |
| Dec 2023 | -$482.02 M(-8.8%) | -$123.46 M(+2.6%) | -$482.02 M(-4.3%) |
| Sep 2023 | - | -$120.38 M(-0.4%) | -$503.81 M(-0.1%) |
| Jun 2023 | - | -$120.86 M(+3.0%) | -$504.36 M(-6.6%) |
| Mar 2023 | - | -$117.32 M(-19.2%) | -$540.08 M(+2.8%) |
| Dec 2022 | -$528.57 M(-16.7%) | -$145.25 M(+20.1%) | -$525.29 M(-24.1%) |
| Sep 2022 | - | -$120.93 M(-22.8%) | -$691.65 M(+1.0%) |
| Jun 2022 | - | -$156.57 M(+52.7%) | -$684.54 M(+7.6%) |
| Mar 2022 | - | -$102.54 M(-67.1%) | -$636.48 M(+0.4%) |
| Dec 2021 | -$634.18 M(-305.4%) | -$311.60 M(+173.8%) | -$634.18 M(+55.2%) |
| Sep 2021 | - | -$113.83 M(+4.9%) | -$408.54 M(-220.6%) |
| Jun 2021 | - | -$108.51 M(+8.3%) | $338.65 M(+5.1%) |
| Mar 2021 | - | -$100.24 M(+16.6%) | $322.13 M(+4.3%) |
| Dec 2020 | $308.71 M(-185.4%) | -$85.97 M(-113.6%) | $308.71 M(-5.1%) |
| Sep 2020 | - | $633.37 M(-606.5%) | $325.29 M(-180.1%) |
| Jun 2020 | - | -$125.04 M(+10.0%) | -$406.03 M(+5.5%) |
| Mar 2020 | - | -$113.66 M(+63.8%) | -$384.91 M(+6.5%) |
| Dec 2019 | -$361.33 M | -$69.38 M(-29.2%) | -$361.33 M(-5.6%) |
| Sep 2019 | - | -$97.96 M(-5.7%) | -$382.73 M(+7.1%) |
| Jun 2019 | - | -$103.91 M(+15.4%) | -$357.47 M(+27.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$90.07 M(-0.8%) | -$280.58 M(+13.6%) |
| Dec 2018 | -$247.03 M(+63.3%) | -$90.78 M(+24.8%) | -$247.03 M(+18.4%) |
| Sep 2018 | - | -$72.71 M(+169.0%) | -$208.58 M(+20.2%) |
| Jun 2018 | - | -$27.02 M(-52.2%) | -$173.53 M(-3.5%) |
| Mar 2018 | - | -$56.52 M(+8.0%) | -$179.86 M(+18.9%) |
| Dec 2017 | -$151.25 M(+110.0%) | -$52.33 M(+39.0%) | -$151.25 M(+25.9%) |
| Sep 2017 | - | -$37.66 M(+12.9%) | -$120.09 M(+21.1%) |
| Jun 2017 | - | -$33.35 M(+19.5%) | -$99.16 M(+17.3%) |
| Mar 2017 | - | -$27.91 M(+31.8%) | -$84.57 M(+17.4%) |
| Dec 2016 | -$72.03 M(+38.3%) | -$21.17 M(+26.6%) | -$72.03 M(+8.7%) |
| Sep 2016 | - | -$16.73 M(-10.9%) | -$66.27 M(+6.9%) |
| Jun 2016 | - | -$18.77 M(+22.1%) | -$62.01 M(+10.6%) |
| Mar 2016 | - | -$15.36 M(-0.3%) | -$56.05 M(+7.6%) |
| Dec 2015 | -$52.07 M(+30.7%) | -$15.41 M(+23.6%) | -$52.07 M(+2.2%) |
| Sep 2015 | - | -$12.47 M(-2.6%) | -$50.98 M(+4.3%) |
| Jun 2015 | - | -$12.80 M(+12.4%) | -$48.89 M(+10.4%) |
| Mar 2015 | - | -$11.39 M(-20.5%) | -$44.28 M(+11.2%) |
| Dec 2014 | -$39.83 M(+91.7%) | -$14.32 M(+37.9%) | -$39.83 M(+56.1%) |
| Sep 2014 | - | -$10.38 M(+26.7%) | -$25.52 M(+68.6%) |
| Jun 2014 | - | -$8.20 M(+18.2%) | -$15.13 M(+118.2%) |
| Mar 2014 | - | -$6.93 M | -$6.93 M |
| Dec 2013 | -$20.77 M | - | - |
FAQ
- What is Blueprint Medicines annual earnings before interest & taxes?
- What is the all time high annual EBIT for Blueprint Medicines?
- What is Blueprint Medicines annual EBIT year-on-year change?
- What is Blueprint Medicines quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Blueprint Medicines?
- What is Blueprint Medicines quarterly EBIT year-on-year change?
- What is Blueprint Medicines TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Blueprint Medicines?
- What is Blueprint Medicines TTM EBIT year-on-year change?
What is Blueprint Medicines annual earnings before interest & taxes?
The current annual EBIT of BPMC is -$482.02 M
What is the all time high annual EBIT for Blueprint Medicines?
Blueprint Medicines all-time high annual earnings before interest & taxes is $308.71 M
What is Blueprint Medicines annual EBIT year-on-year change?
Over the past year, BPMC annual earnings before interest & taxes has changed by +$46.55 M (+8.81%)
What is Blueprint Medicines quarterly earnings before interest & taxes?
The current quarterly EBIT of BPMC is -$37.24 M
What is the all time high quarterly EBIT for Blueprint Medicines?
Blueprint Medicines all-time high quarterly earnings before interest & taxes is $633.37 M
What is Blueprint Medicines quarterly EBIT year-on-year change?
Over the past year, BPMC quarterly earnings before interest & taxes has changed by +$83.14 M (+69.07%)
What is Blueprint Medicines TTM earnings before interest & taxes?
The current TTM EBIT of BPMC is -$89.40 M
What is the all time high TTM EBIT for Blueprint Medicines?
Blueprint Medicines all-time high TTM earnings before interest & taxes is $338.65 M
What is Blueprint Medicines TTM EBIT year-on-year change?
Over the past year, BPMC TTM earnings before interest & taxes has changed by +$414.41 M (+82.25%)